Hipgnosis fails to attract offer above £360m for music catalogues
Shares in Hipgnosis Songs Fund dropped on Tuesday morning following the announcement.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Hipgnosis has said would-be bidders for its proposed music catalogue sale are not willing to match the price of an original 440 million US dollar (£360 million) offer.
Shares in Hipgnosis Songs Fund dropped on Tuesday morning following the announcement.
Last month, the investment firm which buys property rights for music, including songs by Justin Bieber, Shakira and 50 Cent, agreed the sale of 29 catalogues to a private sister fund backed by investment giant Blackstone.
The London-listed business launched a 40-day “go-shop” provision after agreeing the deal, giving other suitors the opportunity to put forward their own offers.
However, on Tuesday, Hipgnosis confirmed it did not receive a superior offer following the process.
A number of the parties assessed that they could not justify paying a higher price than the offer
It said it had been in contact with 17 interested parties and saw eight of those sign non-disclosure agreements (NDAs) but received only one first-round non-binding offer and this did not result in a binding bid.
Hipgnosis told shareholders “a number of the parties assessed that they could not justify paying a higher price than the offer” already on the table.
It will therefore continue to recommend the current offer to shareholders at its annual general meeting later this week.
This comes days after the fund launched a strategic review which could overhaul its management team.
Last week, it also decided to scrap its shareholder dividend payout, which could otherwise have seen it breach the terms of its loan agreements. Its share price plunged as a result.